Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
NovAliX
NovAliX
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
The new F-Gas Regulation and its impact on pharmaceutical freeze-drying
Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex,...
Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development
Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil
Gerresheimer begins €100m expansion of its pharmaceutical syringe production capabilities
The extension of its Skopje, North Macedonia site will allow Gerresheimer to better serve the pharmaceutical and biotech industries
Ipsen licenses Biomunex Pharmaceuticals' bispecific antibody, BMX-502
The deal makes Biomunex eligible for up to $610m, with Ipsen being responsible for getting the cancer immunotherapy into Phase I clinical trials
Europa Biosite acquires life science product and service supplier, AMSBIO
Europa Biosite will now be able to expand its presence across the key US market, while also bolstering its offerings in stem cell research, regenerative medicine and biospecimens
Upcoming event
CPhI Middle East
10–12 December 2024 | Conference | Riyadh, Saudi Arabia
See all
Related Content
Drug Delivery
Galapagos and NovAliX enter integrated drug discovery collaboration
The agreement follows Galapagos’ renewed focus on its key therapeutic areas of oncology and immunology
Manufacturing
NovAliX partners with Chemical.AI on drug discovery AI tookit
The program focuses on enhancing Chemical.AI's computer-aided synthesis planning (CASP) system, to improve its predictive retrosynthesis
Research & Development
NovAliX invests $6.4m in DNA-encoded library platform
As part of the funding, Bpifrance, the French national investment bank, and the Grand Est region, the regional Council in Strasbourg, are providing $2.4m to NovAliX
Research & Development
NovAliX enters drug discovery collaboration with Teijin Pharma
To develop novel drug candidates against multiple targets across different therapeutic areas
Research & Development
NovAliX signs chemistry services deal with Janssen-Cilag
Multi-year agreement will support French firm’s drug discovery efforts
Subscribe now